InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
1
T+90 hit rate
50%
T+90 mean return
-21.3%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Dar Zavain. Officer active across 1 company, notably Recursion Pharmaceuticals, INC.. In total, 21 reports have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €167k. History available since 7 December 2021. The latest transaction was disclosed on 1 April 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations21 total
88,424 sharesClass A Common StockSEC:0001601830-26-000084:0
4,902 shares0Class A Common StockSEC:0001852075-26-000004:0
2,941 shares0Class A Common StockSEC:0001852075-25-000005:0
2,924 shares0Class A Common StockSEC:0001601830-25-000115:0
22,016 shares0Class A Common StockSEC:0001601830-25-000109:0
2,745 shares0Class A Common StockSEC:0001601830-25-000055:0
1,907 shares0Class A Common StockSEC:0001601830-25-000006:0
2,229 shares0Class A Common StockSEC:0001601830-24-000173:0
1,843 shares0Class A Common StockSEC:0001601830-24-000098:0
13,097 shares0Class A Common StockSEC:0001601830-24-000070:0
1,467 shares0Class A Common StockSEC:0001601830-24-000029:0
1,393 shares0Class A Common StockSEC:0001601830-24-000002:0
20,141 shares@ US$9.00100.0% of flowClass A Common StockSEC:0001209191-23-059032:0
1,920 shares0Class A Common StockSEC:0001209191-23-052066:0
1,863 shares0Class A Common StockSEC:0001209191-23-041654:0
12,612 shares0Class A Common StockSEC:0001209191-23-038842:0
1,996 shares0Class A Common StockSEC:0001209191-23-026049:0
1,996 shares0Class A Common StockSEC:0001209191-23-023436:0
2,420 shares0Class A Common StockSEC:0001209191-22-041947:0
18,145 shares0Class A Common StockSEC:0001209191-22-037635:0
3,599 shares0Class A common stockSEC:0000905718-21-001585:0
21 of 21 declarations
About Dar Zavain
Dar Zavain is a director of Recursion Pharmaceuticals, INC.. Across 18 filings in total, the 18 sampled filings cover the period from 2021-12-09 to 2026-06-22, with EUR 0 of purchases and EUR 166514 of sales, mainly tied to an attribution.
